Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Hand

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
The Journal of Laboratory and Clinical Medicine|March 1, 1987
Modulation of human tumor antigen expressionJ W Greiner, P H Hand, D Colcher, et al.
Biotechnology Therapeutics|January 1, 1993
Therapeutic efficacy of a high-affinity anticarcinoembryonic antigen monoclonal antibody (COL-1)K Siler, D Eggensperger, P H Hand, et al.
Cancer Research|March 1, 1987
Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridizationN Ohuchi, P H Hand, G Merlo, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Comparative biological properties of a recombinant chimeric anti-carcinoma mAb and a recombinant aglycosylated variantP H Hand, B Calvo, D Milenic, et al.
Cancer Research|January 1, 1991
Generation and characterization of a recombinant/chimeric B72.3 (human gamma 1)P Hutzell, S Kashmiri, D Colcher, et al.
Cancer|December 1, 1984
Monoclonal antibodies to breast cancer-associated antigens as potential reagents in the management of breast cancerJ Schlom, J Greiner, P H Hand, et al.
Advances in Cancer Research|January 1, 1985
Monoclonal antibodies reactive with breast tumor-associated antigensJ Schlom, D Colcher, P H Hand, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
A CDR-grafted (humanized) domain-deleted antitumor antibodyD C Slavin-Chiorini, S V Kashmiri, H S Lee, et al.
Cancer Immunology, Immunotherapy : CII|December 29, 2000
The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccinesP Arlen, K Y Tsang, J L Marshall, et al.
Cancer Research|February 1, 1990
Innovations that influence the pharmacology of monoclonal antibody guided tumor targetingJ Schlom, P H Hand, J W Greiner, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
The Journal of Laboratory and Clinical Medicine|March 1, 1987
Modulation of human tumor antigen expressionJ W Greiner, P H Hand, D Colcher, et al.
Biotechnology Therapeutics|January 1, 1993
Therapeutic efficacy of a high-affinity anticarcinoembryonic antigen monoclonal antibody (COL-1)K Siler, D Eggensperger, P H Hand, et al.
Cancer Research|March 1, 1987
Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridizationN Ohuchi, P H Hand, G Merlo, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Comparative biological properties of a recombinant chimeric anti-carcinoma mAb and a recombinant aglycosylated variantP H Hand, B Calvo, D Milenic, et al.
Cancer Research|January 1, 1991
Generation and characterization of a recombinant/chimeric B72.3 (human gamma 1)P Hutzell, S Kashmiri, D Colcher, et al.
Cancer|December 1, 1984
Monoclonal antibodies to breast cancer-associated antigens as potential reagents in the management of breast cancerJ Schlom, J Greiner, P H Hand, et al.
Advances in Cancer Research|January 1, 1985
Monoclonal antibodies reactive with breast tumor-associated antigensJ Schlom, D Colcher, P H Hand, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
A CDR-grafted (humanized) domain-deleted antitumor antibodyD C Slavin-Chiorini, S V Kashmiri, H S Lee, et al.
Cancer Immunology, Immunotherapy : CII|December 29, 2000
The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccinesP Arlen, K Y Tsang, J L Marshall, et al.
Cancer Research|February 1, 1990
Innovations that influence the pharmacology of monoclonal antibody guided tumor targetingJ Schlom, P H Hand, J W Greiner, et al.
Pageof 5